BCAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: BCAT1 is upregulated and functionally required for several malignancies including glioblastoma, hepatocellular carcinoma (HCC), colorectal and breast cancers, and chronic myelogenous leukemia [26].